In the Phase I study, the investigators injected an adeno-associated virus (AAV) vector carrying an inhibitory gene (glutamic acid decarboxylase or GAD) into one side of the subthalmic
Genelabs and Tanabe Seiyaku, a predecessor company to Mitsubishi Tanabe, signed their collaboration and license agreement in January 2004. The agreement provided that Tanabe was responsible for conducting
The study will be sponsored by the Division of Microbiology and Infectious Diseases of the National Institute of Allergy and Infectious Diseases, an institute of the National Institutes
Triolex, a novel orally bio-available anti-inflammatory cleared by the FDA for a Phase I/II clinical trial in rheumatoid arthritis (RA), has also demonstrated benefit to date in animal
The Sarnow patent, a Stanford University patent to which Regulus has exclusive rights, relates to the discovery and development of therapeutic products for hepatitis C virus (HCV) infection
According to Bayer and Onyx, Nexavar (sorafenib), an oral anticancer drug, is the first approved systemic therapy for liver cancer and the only one shown to significantly improve
The agreement grants Dr Reddy’s exclusivity in the US for the distribution and marketing of EpiCeram while Ceragenix will be responsible for the manufacturing and supply of the
With 540 patients enrolled by 40 specialist clinical centers in the US, Canada and South Africa, the company has achieved its target ahead of schedule. The trial results
The co-primary endpoints for these studies will evaluate the differences between treatments from baseline to the end of the treatment period, in mean percent weight loss and in
The European Medicines Agency’s (EMEA) orphan medicinal product designation is intended to promote the development of drugs which may provide significant benefits to patients suffering from life-threatening or
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.